Spectra Intelligence, April 2006, Pages: 369
, who reviewed the report, said “Dr Crawford has provided an exceptionally comprehensive first-rate analysis of our current understanding of cancer biology, cancer treatment approaches, diagnosis
John Wiley and Sons Ltd, Feb 2012, Pages: 496
. This is the only reference and clinical book on the market for cancer genetics counselors and other healthcare providers who must quickly assimilate complex and ever-changing data on the hereditary risk for cancer
Business Insights, Jan 2011, Pages: 130
applied to diagnosis in breast cancer and Alzheimer’s disease?
- What are the business models of some of the major diagnostic companies as they establish new integrated diagnostic and healthcare
GlobalData, Jan 2012, Pages: 147
Cancer Vaccines - Pipeline Assessment and Market Forecasts to 2018
Summary
GlobalData, the industry analysis specialist, has released its new report, “Cancer Vaccines - Pipeline Assessment
Business Insights, June 2011, Pages: 187
covered include: breast cancer; colon cancer; prostate cancer; non-small cell lung cancer; melanoma; and renal cancer. This report reviews the direction of research, and key issues facing the industry
GlobalData, Dec 2011, Pages: 128
. Pipeline candidates fall under major therapeutic classes.
- Analysis of the current and future competition in the seven key countries Cervical Cancer Therapeutics market.
- Insightful review of the key
Global Industry Analysts, Inc., Oct 2011, Pages: 897
to Claim
the Top Spot 5
Cancer Therapies: A Review 6
Enduring Success of Top Drug Makers Makes Oncology Area More
Endearing 7
Table 1: Select Leading Cancer Therapies Worldwide by
Revenues: 2006
GlobalData, Dec 2011, Pages: 98
Gallbladder Cancer Global Clinical Trials Review, H2, 2011
Summary
GlobalData's clinical trial report, “Gallbladder Cancer Global Clinical Trials Review, H2, 2011" provides data on the Gallbladder
Decision Resources, Inc., Dec 2009, Pages: 58
Given the life-threatening nature of cancer and the effectiveness and tolerability of many targeted oncology drugs, healthcare payers have typically been willing to provide generous coverage
Global Industry Analysts, Inc., Feb 2010, Pages: 220
) II-4
Competitive Scenario: II-4
Current Market Conditions II-4
Impact of Recession II-4
Key Market Trends & Issues: A Review II-5
Continuous Fight Against Cancer: A Key Propeller for Growth II-5
TriMark Publications, July 2011, Pages: 267
Markers
11.7 Genetic Profiling
11.8 Ploidy
11.9 Advances in Sputum Analysis for Screening and Early Detection of Lung Cancer
11.10 Pharmacogenetic Tests for Cancer
11.11 Worldwide Healthcare Spending
GlobalData, Dec 2011, Pages: 84
Oral Cancer Global Clinical Trials Review, H2, 2011
Summary
GlobalData's clinical trial report, “Oral Cancer Global Clinical Trials Review, H2, 2011" provides data on the Oral Cancer clinical
GlobalData, Dec 2011, Pages: 81
Testicular Cancer Global Clinical Trials Review, H2, 2011
Summary
GlobalData's clinical trial report, “Testicular Cancer Global Clinical Trials Review, H2, 2011" provides data on the Testicular
Jain PharmaBiotech, Feb 2012, Pages: 772
. Nanobiotechnology, an integration of physical sciences, molecular engineering, biology, chemistry and biotechnology holds considerable promise of advances in pharmaceuticals and healthcare. The report starts
GlobalData, Jan 2012, Pages: 90
Oropharyngeal Cancer Global Clinical Trials Review, H1, 2012
Summary
GlobalData's clinical trial report, “Oropharyngeal Cancer Global Clinical Trials Review, H1, 2012" provides data
Jain PharmaBiotech, Feb 2012, Pages: 299
This report briefly reviews basics of human genome variations, development of sequencing technologies, and their applications. Current large and small sequencers are described as well as companies
GlobalData, Nov 2011, Pages: 70
Vaginal Cancer Global Clinical Trials Review, H2, 2011
Summary
GlobalData's clinical trial report, “Vaginal Cancer Global Clinical Trials Review, H2, 2011" provides data on the Vaginal Cancer
GlobalData, Dec 2011, Pages: 123
Head and Neck Cancer Global Clinical Trials Review, H2, 2011
Summary
GlobalData's clinical trial report, “Head and Neck Cancer Global Clinical Trials Review, H2, 2011" provides data on the Head
